Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010-2013

94Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

We aimed to clarify changes in serotypes and genotypes mediating β-lactam and macrolide resistance in Streptococcus pneumoniae isolates from Japanese children who had invasive pneumococcal disease (IPD) after the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into Japan; 341 participating general hospitals conducted IPD surveillance during April 2010-March 2013. A total of 300 pneumococcal isolates were collected in 2010, 146 in 2011, and 156 in 2012. The proportion of vaccine serotypes in infectious isolates decreased from 73.3% to 54.8% to 14.7% during the 3 years. Among vaccine serotype strains, genotypic penicillin-resistant S. pneumoniae strains also declined each year. Among nonvaccine serotype strains, 19A, 15A, 15B, 15C, and 24 increased in 2012. Increases were noted especially in genotypic penicillin-resistant S. pneumoniae isolates of serotypes 15A and 35B, as well as macrolide resistance mediated by the erm(B) gene in 15A, 15B, 15C, and 24.

Cite

CITATION STYLE

APA

Chiba, N., Morozumi, M., Shouji, M., Wajima, T., Iwata, S., & Ubukata, K. (2014). Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010-2013. Emerging Infectious Diseases, 20(7), 1132–1139. https://doi.org/10.3201/eid2007.131485

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free